(Q34635024)

3 August 2017

1 reference

title

The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors (English)

1 reference

3 August 2017

1 reference

Madkan VK

1

1 reference

3 August 2017

Cook-Norris RH

2

1 reference

3 August 2017

Steadman MC

3

1 reference

3 August 2017

Arora A

4

1 reference

3 August 2017

Mendoza N

5

1 reference

3 August 2017

Tyring SK

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

6 June 2007

1 reference

British Journal of Dermatology

3 August 2017

published in

1 reference

3 August 2017

volume

157

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

228-241

1 reference

Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Association of p53 arginine polymorphism with skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Host and viral genetics and risk of cervical cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The association between non-melanoma skin cancer and a young dimorphic Alu element within the major histocompatibility complex class I genomic region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Genetic susceptibility to HPV infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Anal cancer in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Papillomaviruses in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Environmental co-factors in HPV carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

THE EFFECT OF CHEMICAL CARCINOGENS ON VIRUS-INDUCED RABBIT PAPILLOMAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Sexually transmitted agents and cervical neoplasia in Colombia and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Variations in mortality by weight among 750,000 men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Obesity and cancer risk: a Danish record-linkage study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

A prospective study of obesity and cancer risk (Sweden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07961.X

10.1111/J.1365-2133.2007.07961.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference